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Myocardial perfusion cardiovascular magnetic resonance (CMR) has become an established method for the non-
invasive diagnosis of coronary artery disease (CAD).1,2 It is 
accurate and in recent studies was shown to be noninferior to 
single-photon emission computer-assissted tomography myo-
cardial perfusion scintigraphy (SPECT MPS).1,3 However, the 
cardiac coverage provided by conventional myocardial perfu-
sion CMR methods is limited to 3 short-axis sections that cover 
16 of the 17 myocardial segments defined by guidelines but 
with variable gaps between the acquired sections.4 Although 
this may be sufficient for diagnostic purposes, the selective 
spatial coverage may prevent an accurate measurement of isch-
emic burden.5 In clinical practice, ischemic burden is most com-
monly measured by MPS. It is an important prognostic factor 
in CAD6,7 and in accordance with guidelines can help identify 
patients who will benefit most from revascularization compared 
with medical therapy.8,9
Clinical Perspective on p 654
In a recent subanalysis of the Clinical Evaluation of Magnetic 
Resonance Imaging in Coronary Heart Disease (CE-MARC) 
study, ischemic burden was compared between MPS and con-
ventional 2-dimensional CMR perfusion. Although there was 
good agreement for overall ischemic burden, discrepancies in 
the detection of ischemia versus scar were noted, thought to be 
related at least in part to the differences in cardiac coverage of 
perfusion CMR and perfusion MPS and also between perfu-
sion MPS and late gadolinium enhancement (LGE) CMR.10
Background—The extent and severity of ischemia on myocardial perfusion scintigraphy (MPS) is commonly used to risk-
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(CMR) with conventional 2-dimensional myocardial perfusion methods is limited by incomplete cardiac coverage. More 
recently developed 3-dimensional (3D) myocardial perfusion CMR, however, provides whole-heart coverage. The aim of 
this study was to compare ischemic burden on 3D myocardial perfusion CMR with 99mTc-tetrofosmin MPS.
Methods and Results—Forty-five patients who had undergone clinically indicated MPS underwent rest and adenosine stress 
3D myocardial perfusion and late gadolinium enhancement CMR. Summed stress and rest scores were calculated for 
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Recently proposed 3-dimensional (3D) myocardial perfu-
sion CMR techniques overcome the problem of limited cardiac 
coverage and are also accurate in the detection of CAD.5,11–13 
Measurements of ischemic burden from 3D myocardial perfu-
sion CMR have been shown to agree with invasive indices of 
myocardium at risk12 and to reduce following percutaneous 
coronary intervention.14 However, a direct comparison with 
MPS has not previously been reported.
The main objective of this study was, therefore, to compare 
ischemic burden between MPS and 3D myocardial perfusion 
CMR. Diagnostic accuracy of the 2 methods against invasive 
coronary angiography was also assessed in a subset of patients.
Methods
Patient Population
The study was approved by the local research ethics committee, and 
all subjects gave written informed consent to participate. Forty-six 
patients routinely referred for MPS to the Royal Brompton Hospital, 
London, United Kingdom, were consecutively recruited to undergo 
CMR within the following 14 days. The MPS studies were reported 
as part of clinical routine and the report available to the referring 
physician to guide patient management. Exclusion criteria were con-
traindications to CMR or adenosine stress and the presence of atrial 
fibrillation. On the procedure day, a full medical history and exami-
nation were undertaken. Symptoms of chest pain were recorded in 
accordance with the Canadian Cardiovascular Society angina grading 
scale. A resting ECG was analyzed for the presence of Q waves or 
bundle branch block using defined Minnesota criteria.15
MPS Acquisition
All patients underwent 1-day stress–rest16 ECG-gated 99mTc-tetrofos-
min MPS using a dual-headed gamma camera (Philips CardioMD) 
fitted with 153Gd transmission sources. Patients were asked to abstain 
from caffeine for 12 hours before the study and to have only a light 
breakfast. Adenosine was infused at 140 μg/kg/min for 6 minutes 
combined with semisupine exercise on a bicycle ergometer in 2-min-
ute stages of 25 W, 50 W, and 75 W if tolerated. In patients with 
left bundle branch block or bifasicular block, adenosine was infused 
without exercise. A 250 MBq 99mTc-tetrofosmin was injected 2 min-
utes before the end of stress with imaging 45 to 60 minutes after injec-
tion. Three hours later, 750 MBq 99mTc-tetrofosmin was given at rest 
5 minutes after 200 μg sublingual glyceryl trinitrate, with imaging 
45 to 60 minutes later. The total effective radiation dose was 8 mSv.
MPS Interpretation
For the purpose of this study, all MPS studies were reported by an ob-
server blinded to all clinical data and the previous clinical MPS report. 
The analysis undertaken for the purpose of this study was not made 
available to the patient’s clinician. Transverse tomograms of the left 
ventricle were reconstructed using iterative reconstruction on a Hermes 
workstation (Hermes Medical Systems, Stockholm). Transaxial slices 
were reoriented to obtain short-axis, horizontal long-axis, and vertical 
long-axis views of the left ventricle. Attenuation correction and reso-
lution recovery were used. Unprocessed planar images were displayed 
in the cine format to assess quality and to assess patient motion and at-
tenuation. Image artifact was scored on a 4-point scale from 0 (none), 
1 (mild), 2 (moderate), and 3 (severe). Image quality was scored on a 
similar scale using the reconstructed tomograms taking into account 
the severity of artifact score and overall clinical value as follows:
1. Q3: excellent quality images with no artifact
2. Q2: good quality images with total artifact score of ≤2
3. Q1: adequate quality images with total artifact score of ≥3
4. Q0: inadequate quality images with artifact severe 
enough to affect diagnostic quality
The tomographic slices were divided into 17 segments4 and mean 
segmental counts were graded semiquantitatively by an experienced 
observer: 0=normal uptake (≥70% of maximum activity), 1=mild re-
duction (50%–69%), 2=moderate reduction (30%–49%), 3=severe 
reduction (10%–29%), and 4=absent uptake (0%–9%). The summed 
stress score and summed rest score were obtained by adding seg-
mental scores, and the summed difference score (ie, summed stress 
score–summed rest score) expressed as a percentage of 68, the the-
oretical maximum score, was used as a measure of total ischemic 
burden.17
Each study was also classified as normal or showing reversible, 
fixed, or mixed defects. A subjective confidence score of 3 (definite 
confidence), 2 (moderate confidence), 1 (mild confidence), to 0 (un-
certain) was assigned to the classification.
CMR Acquisition
All subjects were scanned in a supine position using a 3T mag-
netic resonance scanner (Achieva; Philips Healthcare, Best, the 
Netherlands) equipped with dual-source parallel radio frequency 
transmission (multitransmit) technology18 and a 6-channel cardiac 
phased array receiver coil. Patients were asked to refrain from caf-
feine-containing substances for 12 hours before CMR. Subjects were 
monitored throughout the scan with a 4-lead vectorcardiogram, respi-
ratory belt, and blood pressure monitoring. For perfusion imaging, a 
3D spoiled turbo gradient echo sequence was used (repetition time/
echo time/flip angle 1.8 ms/0.7 ms/15°, saturation prepulse delay 150 
milliseconds, acquisition timed to end systole, 75% partial Fourier 
sampling in the ky and kz direction and an elliptical k-space shutter, 
10-fold k-t acquisition with 49 training profiles leading to a net ac-
celeration of 7.0, total number of acquired profiles 106, which results 
in an acquisition time per heartbeat of 191 milliseconds [106×1.8 
milliseconds], k-t principal component analysis reconstruction,11,19 
reconstruction of 12 contiguous slices of 5 mm thickness, field of 
view 350×245 mm2, acquired voxel size 2.3×2.3×5 mm3, interpolated 
to 1.5×1.5×5 mm3).
Stress perfusion images were acquired during intravenous adenos-
ine-induced hyperemia administered at 140 μg/kg/min. An intrave-
nous bolus of 0.075 mmol/kg gadobutrol (Gadovist, Bayer, Germany) 
was administered at a rate of 4.0 mL/s followed by a 20-mL saline 
flush (Spectris Solaris power injector, PA).
Stress perfusion CMR was followed by cine imaging covering the 
left ventricle in 10 to 12 short-axis sections and a rest perfusion scan 
performed 15 minutes later using the same concentration and volume 
of contrast agent as for stress perfusion. LGE images (0.15 mmol/kg 
cumulative dose) were acquired in the same short-axis geometry after 
a further 15 minutes using a conventional method.20
CMR Analysis
An experienced observer blinded to all previous test results ana-
lyzed the CMR images using standard software (ViewForum, Philips 
Healthcare, Best, the Netherlands). The CMR data and analysis were 
not made available to the patient’s clinician. Stress and rest perfusion 
scans were viewed simultaneously. Image artifacts were scored using 
a 4-point scale from 0 (none), 1 (mild), 2 (moderate), and 3 (severe). 
The artifact was categorized as breathing related, subendocardial rim 
artifact, or related to the reconstruction of undersampled data. Image 
quality was graded in the same way as MPS on a score of Q3 to Q0.
An inducible perfusion defect was considered to be present if there 
was reduced or delayed segmental delivery of contrast to the myocar-
dium during stress persisting for >4 cardiac cycles, not present on the 
rest perfusion images. This analysis strategy is consistent with recom-
mended reporting guidance to exclude artifacts.21 For calculation of 
ischemic burden, each segment was scored on a 5-point scale taking 
into account the transmurality of the stress perfusion defect: 0 normal 
(0%–24%), 1 mild defect (25%–49%), 2 moderate defect (50%–74%), 
3 severe reduction (75%–100%), and 4 thinned with persistent absent 
contrast delivery. Viable myocardium was assessed using the LGE 
images, scored in a similar way for transmurality of enhancement 
with 0 representing no enhancement, 1 mild enhancement (1%–24%), 
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2 moderate enhancement (25%–49%), 3 severe enhancement (50%–
74%), and 4 transmural enhancement (≥75%).
As for MPS, a confidence score of 3 (definite confidence), 2 (mod-
erate confidence), 1 (mild confidence), to 0 (uncertain) was subjec-
tively assigned to the classification.
In accordance with MPS analysis, the summed stress score and 
summed rest score taken from the LGE images were obtained by add-
ing segmental scores, and the summed difference score (ie, summed 
stress score–summed rest score) was expressed as a percentage of 
68, the theoretical maximum score, was used as a measure of total 
ischemic burden.
Whole-Heart Versus 3-Slice Comparison
We aimed to determine whether ischemic burden measured from 
whole-heart myocardial perfusion CMR agrees more closely with 
SPECT than the conventional 2D myocardial perfusion CMR meth-
ods, which usually provide only 3-slice coverage. Although no origi-
nal 2D CMR data were acquired in this study, analysis of 3 slices of 
the whole-heart data sets was considered a reasonable approximation 
for conventional 2D 3 slice methods. Several limitations of this ap-
proach relating to cardiac phase, spatial, and temporal resolution are 
explicitly acknowledged and will be discussed. For this analysis, all 
data sets were reanalyzed after 4 weeks by a reviewer blinded to all 
previous analyses and clinical data. Only slices 3, 7, and 11, repre-
senting apical, midmyocardial, and basal sections, were shown to the 
reviewer. All scoring was repeated using a 16-segment model that 
excluded the true apex.
Reproducibility
Analysis of MPS and CMR was repeated by the same reader at a 
remote time in a subset of 16 patients.
Coronary Angiography
Treating physicians decided the clinical management of patients in-
cluding the referral for invasive angiography based on the clinical 
MPS report and all other clinical information. Data obtained as part 
of this research were not released to treating physicians. Clinically 
indicated coronary angiography performed within 8 weeks of MPS 
was reviewed for this study. X-ray angiograms were reported by an 
experienced cardiologist blinded to the other studies. Significant 
CAD was defined as ≥70% stenosis of a first-order coronary artery 
measuring ≥2 mm in diameter or LMS stenosis ≥50%, by quantitative 
coronary angiography (Medcon Ltd, Tel Aviv, Israel).
Statistical Analysis
Data were analyzed using IBM SPSS v19 (SPSS, Chicago, IL). 
Differences in mean ischemic burden used Bland–Altman analysis 
and Wilcoxon test. Comparisons of ischemic burden used Spearman 
correlation. The comparison of ischemia burden of CMR perfusion 
with MPS in 45 patients will deliver a power of ≥ 80% at a 95% 
significance level to determine agreement between the tests. The in-
traobserver variability of perfusion analysis was calculated using the 
κ coefficient. McNemar test was used to compare the accuracy of the 
noninvasive test against the standard of coronary angiography. For all 
analyses P<0.05 was considered significant.
Results
Patients
Of the 46 patients recruited, one was excluded because of a 
technical fault during the CMR study, in which contrast was 
injected too early preventing acquisition of the first pass perfu-
sion under hyperemia. Forty-five patients (31 men, mean age 
59) thus formed the population for analysis. The indication for 
referral was diagnosis of CAD in 26 patients (58%) without a 
prior history of CAD. In this population, the pretest likelihood 
of underlying CAD was 37.8% (95% CI, 31.8%–43.9%). 
Nineteen patients had a previous history of CAD with 15 hav-
ing had previous documented myocardial infarction (Table 1). 
Thirty-nine patients experienced symptoms during CMR stress 
perfusion compared with 35 patients during MPS (P=0.27).
Myocardial Perfusion Scintigraphy
Hemodynamic data are shown in Table 2. All studies were 
considered interpretable with a median image quality score 
of 3 and a median confidence score of 2. The main artifacts 
reported were motion (6/45) and attenuation (6/45). Intraob-
server variability showed agreement in 15 of 16 cases (κ=0.88) 
for the detection of ischemia.
CMR Imaging
The mean time from MPS to CMR was 9 days (range, 3–14 
days). Mean scan time was 47 minutes (SD=4). Hemodynamic 
Table 1. Patient Demographics
Parameter Data (%)
Number 45
Male 32 (71.1)
Age, y 58.9±7.7
  Range 44–76
BMI, kg/m2 25.8±2.8
Previous myocardial infarction 15 (33.3)
Previous coronary intervention 16 (35.6)
Normal LV function (EF>60%) 41 (91.1)
Canadian Cardiovascular Society Angina Grading Scale
  No pain or atypical symptoms 27 (60.0)
  Class 1 9 (20.0)
  Class 2 6 (13.3)
  Class 3 3 (6.7)
  Class 4 0 (0)
Baseline ECG
  Q wave 7 (15.6)
  Left bundle branch block 5 (11.1)
  Right bundle branch block 1 (2.2)
Cardiovascular risk factors
  Diabetes mellitus 16 (35.6)
  Dyslipidemia 41 (91.1)
  Current smoker 12 (26.7)
  Hypertension 38 (84.4)
  Family history 22 (48.9)
Medications
  Aspirin 41 (91.1)
  Clopidogrel 7 (15.6)
  β-blocker 27 (60.0)
  Calcium channel blocker 5 (11.1)
  Statin 41 (91.1)
  Angiotensin enzyme inhibitor or 
angiotensin receptor blocker
33 (73.3)
  Nitrate 12 (17.8)
BMI indicates body mass index; EF, ejection fraction; and LV, left ventricle.
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data are shown in Table 2. Compared with MPS, there were 
significant differences in stress blood pressure and heart rate, 
reflecting the differing stress regimes. All 45 CMR studies were 
of interpretable quality. The median image quality score was 3 
and the median confidence score was 3. The main artifacts seen 
were subendocardial dark rim artifacts in 7 patients (16%) and 
breathing artifact in 4 patients (9%). There was 100% intraob-
server agreement for the presence of ischemia (κ=1).
Comparison of Ischemic Burden by MPS and CMR
MPS and CMR agreed for the presence or absence of inducible 
ischemia in 38 of 45 patients (84%; Figures 1 and 2). The mean 
ischemic burden by MPS in all 45 patients was 7.5% (SD, 8.9; 
range, 0–29.4) and by CMR 6.8% (SD, 9.5; range, 0–33.8) 
with good correlation and no significant differences between 
methods (rs=0.70; P=0.82). In the 38 patients in whom the 
tests agreed, the correlation for ischemic burden was stron-
ger (rs=0.96; P<0.0001; Figure 3). The mean bias for isch-
emic burden between the 2 methods (CMR minus MPS) was 
–0.62% (95% limit of agreement, –14.3 to 13.1%; Figure 4).
Twelve patients had an ischemic burden >10% on MPS, 
and of these, CMR ischemic burden was >10% in 11 patients. 
Conversely, 2 patients had CMR ischemic burden >10% but 
<10% by MPS, although the differences were small (10.3% 
and 10.3% by CMR versus 8.8% and 7.5% by MPS).
When only 3 short-axis slices were used for CMR analysis, 
the mean ischemic burden was lower at 5.7% (SD, 8.2). There 
was no significant difference in the ischemic burden between 
Figure 1. Images from a 47-year-old man with atypical chest pain and multiple risk factors for coronary artery disease are shown. The 
patient had no known prior myocardial infarction. A and B, Cardiovascular magnetic resonance (CMR) perfusion scans during adenos-
ine stress and late gadolinium enhancement (LGE) CMR. A perfusion defect is seen in the anterior and anteroseptal segments from the 
base to the apex extending into the inferior wall. LGE shows subendocardial scar in the septal segments from the mid ventricle to the 
apex. The ischemic burden by CMR was 20.5%. C and D, Rest and stress myocardial perfusion scintigraphy (MPS). Stress MPS shows 
extensive and profound inducible ischemia involving most of the left anterior descending (LAD) coronary artery territory and further inferior 
changes corresponding with the stress CMR images. Rest MPS shows reduced uptake in the LAD territory toward and including the apex 
that is less marked than on the stress images. The study was reported as showing partial infarction in the LAD territory with a large area 
of peri-infarct ischemia. The ischemic burden by MPS was 19.8%. Invasive X-ray angiography showed an occlusion of the proximal left 
anterior descending coronary artery with collateral supply from the right coronary artery, which had a mid course stenosis.
Table 2. Hemodynamic Data
Rest Stress
MPS CMR P MPS CMR P
HR 72.9±11.6 72.0±11.6 0.42 102.2±17.7 89.5±13.6 <0.0001
SBP 139.8±18.7 135.2±12.6 0.08 153.3±23.3 130.5±22.6 0.008
DBP 81.6±13.4 80.0±19.6 0.4 88.1±21.2 80.1±12.7 <0.0001
RPP 10 250±2408 9825±2769 0.19 15 810±4365 11 841±3568 <0.0001
CMR indicates cardiovascular magnetic resonance; DBP, diastolic bold pressure; HR, heart rate; MPS, myocardial perfusion scintigraphy; 
RPP, rate pressure product; and SBP, systolic blood pressure.
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MPS and 3-slice perfusion (P=0.12). However, there was a 
significant difference in ischemic burden between whole-heart 
CMR and 3-slice CMR perfusion analysis (P=0.03). There 
was good correlation between 3-slice analysis and MPS isch-
emic burden (rs=0.72) and excellent correlation with whole-
heart CMR analysis (rs=0.97).
Scar Burden
CMR and MPS agreed for the presence or absence of myo-
cardial scar in 38 of 45 patients (84%). Scar was detected by 
LGE CMR in 14 of 45 patients (31%) and in 11 of these also 
by MPS. Four patients had scar reported on MPS that was 
not present on LGE CMR. Taking CMR as the reference, the 
sensitivity of MPS for scar was 79% (95% CI, 49%–94%) and 
specificity 87% (95% CI, 69%–96%). The mean scar burden 
was higher with MPS than CMR (4.9% SD 10% versus 3% 
SD 6.8%), but this was not statistically significant (P=0.06). 
In all 45 patients, the correlation between the 2 tests for scar 
burden was good (rs=0.73), and in the 38 cases in which CMR 
and SPECT agreed, there was stronger agreement (rs=0.99).
Diagnostic Accuracy Against Coronary 
Angiography
Of the 45 patients, 33 underwent coronary angiography for 
clinical reasons, of whom 17 were found to have significant 
Figure 2. Images from a 58-year-old man with a previous myocardial infarction and subsequent revascularization with ongoing chest pain 
are shown. A and B, Cardiovascular magnetic resonance (CMR) perfusion scan during adenosine stress and corresponding late gado-
linium enhancement images. A subendocardial perfusion defect is seen in the basal inferolateral wall extending to the mid inferolateral 
wall. Late gadolinium enhancement CMR shows a small area of subendocardial scar in the same region, but the perfusion deficit extends 
beyond the equivalent imaging plane. The ischemic burden by CMR was 8.8%. C and D, Stress and rest myocardial perfusion scintig-
raphy (MPS) imaging shows corresponding limited partial-thickness scarring in the basal inferolateral region with mild superimposed 
and peri-infarct ischemia extending up to the mid inferolateral region. The ischemic burden by MPS was 7.4%. The coronary angiogram 
showed a significant stenosis in a large first obtuse marginal branch.
Figure 3. Correlation between myocardial perfusion scintigraphy 
(MPS) and cardiovascular magnetic resonance (CMR) for isch-
emic burden in the patients where there was agreement between 
the techniques (38/45): The dotted line indicates 10% ischemic 
burden.
Figure 4. Bland–Altman analysis of ischemic burden between the 
techniques in the cohort of patients where there was agreement 
between the techniques (38/45). Bland–Altman analysis showed a 
mean bias for ischemic burden between the 2 methods of 0.62% 
(95% CI, –7.98% to 9.21%). CMR indicates cardiovascular mag-
netic resonance; and MPS, myocardial perfusion scintigraphy.
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coronary disease (disease prevalence 52%). The overall sensi-
tivity, specificity, and diagnostic accuracy of MPS were 94% 
(95% CI, 71%–100%), 63% (95% CI, 39%–87%), and 79%. 
The positive and negative predictive values were 72.7% and 
90.9%, respectively. The sensitivity, specificity, and diagnostic 
accuracy of CMR was 94% (95% CI, 71%–100%), 81% (95% 
CI, 54%–95%), and 88% (Table 3). The positive and negative 
predictive values were 84.2% and 92.9%, respectively. Diag-
nostic performance of both tests depended on image quality 
and confidence scores (Table 4). The overall accuracy of the 
2 techniques did not differ significantly (McNemar P=0.45).
Discussion
3D myocardial perfusion CMR has become feasible because of 
increased speed of data acquisition.11 Its value for the calcula-
tion of ischemic burden was first suggested in a phantom study, 
which showed that 3D imaging was more reliable than the con-
ventional 2D techniques.5 Subsequent studies demonstrated 
the feasibility of measuring ischemic burden, a reduction in 
ischemic burden after coronary intervention14 and a strong 
correlation with the invasively derived Duke jeopardy score.12 
The current study has now shown that ischemic burden by 3D 
myocardial perfusion CMR agrees closely with the clinical 
reference standard of MPS and that both methods have similar 
accuracy for the detection of angiographically significant CAD.
The presence of myocardial ischemia is relevant prognosti-
cally, and an ischemic burden >10% of total myocardium is 
a threshold above which revascularization leads to better out-
comes than with medical therapy alone.17,22 Most data on isch-
emic burden have been derived from MPS,6,7,17,22 justifying the 
comparison of 3D myocardial perfusion CMR with MPS in this 
study. In addition to the close overall agreement between the 
techniques we found that in 11 of 12 patients with an ischemic 
burden >10% by MPS, the ischemic burden by CMR was also 
>10%. Conversely, CMR only slightly overestimated ischemic 
burden in 2 patients with an ischemic burden <10% by MPS.
This suggests that the 10% MPS threshold for improved 
outcome with intervention might also be used for 3D myocar-
dial perfusion CMR, but prospective studies will be required 
to confirm this.
Scar Burden
LGE CMR is an established technique for the detection of 
myocardial scarring, and it is sensitive to even small amounts 
of infarction.20,23 MPS is widely used for the detection infarc-
tion and it is well validated for its quantification although it is 
less sensitive than CMR for small areas of infarction because 
of its lower spatial resolution.24 In this study, there was overall 
good correlation between CMR and MPS for the detection and 
quantification of scar, but numbers were too small to formally 
assess the relationship between infarct size and agreement 
between the two methods.
Detection of CAD
In the subgroup of patients that underwent coronary angiog-
raphy, the sensitivity of 3D perfusion CMR was similar to 
previous studies. MPS had a similar high sensitivity but the 
specificity was nonsignificantly lower because of 6 false-pos-
itive cases. A breakdown into image quality and confidence 
scores showed that diagnostic performance was greater with 
better quality images for both tests.
Whole-Heart Versus 3-Slice Analysis
Because of its full cardiac coverage, estimates of ischemic bur-
den from 3D myocardial perfusion CMR may correlate better 
with SPECT measurements than estimates based on 2D myo-
cardial perfusion CMR. To investigate this question, we cal-
culated ischemic burden from 3 slices of the whole-heart data 
set and compared it with whole-heart CMR analysis using all 
slices of the 3D data set and SPECT data. We acknowledge that 
this approach cannot be considered a full substitute for origi-
nal 2D acquisition. For example, as compared to a previously 
published 2D acquisition method using k-t acceleration,25 the 
selected 3 slices of the 3D stack have lower in-plane spatial 
resolution (2.3 mm versus 1.4 mm), a longer temporal acquisi-
tion window (193 milliseconds versus 120 milliseconds), but 
have thinner slices (5 mm versus 10 mm), require faster accel-
eration (10× versus 5×), and acquire all of the data in an end-
systolic heart phase instead of at 3 different cardiac phases. 
These differences between 2D acquisition and the simulation 
we used in our study may affect the detection of subendocar-
dial ischemia in slices acquired during diastolic time points or 
during rapid motion. Our analysis can, therefore, only give an 
initial indication of the effects of whole-heart versus 2D perfu-
sion CMR on estimates of ischemic burden, and direct com-
parisons between 2D and 3D imaging are needed in the future.
Although there was a difference in ischemic burden between 
the 3 slice and whole-heart analysis, there was no difference in 
assigning patients to either medical therapy when using a thresh-
old of 10% ischemic burden. There was a trend toward a smaller 
ischemic burden from the 3-slice CMR analysis (6.8% versus 
5.7%, P=0.03). The lower ischemic burden is likely to be a con-
sequence of the reduced number of slices influencing reporting of 
ischemia, leading to an underestimation of ischemia. Within its 
limitations, the comparison of whole heart versus 3-slice analysis 
raises questions about the relative benefits of spatial resolution, 
temporal resolution, signal-to-noise ratio, and cardiac phase that 
need to be explored in future studies. Further differences between 
the techniques are discussed in more detail elsewhere.26
Limitations
This study investigated a population with a relatively high 
prevalence of scar, but we were primarily interested in the 
Table 3. MPS and CMR vs Coronary Angiography
Angiography: Significant Coronary Disease
Absent Present Total
CMR+ 3 16 19
CMR– 13 1 14
 Total 16 17 33
MPS+ 6 16 22
MPS– 10 1 11
 Total 16 17 33
CMR indicates cardiovascular magnetic resonance; and MPS, myocardial 
perfusion scintigraphy.
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assessment of ischemic burden independently of scar. The 
presence of scar may complicate the detection of superimposed 
inducible ischemia, and it is possible that the assessment of 
ischemia would be more accurate in populations without scar.
There were inevitable differences in the acquisition and 
measurement of ischemic volume between MPS and CMR. 
We equated the transmurality of a CMR perfusion defect 
to the depth of the defect of tracer uptake on MPS. These 2 
phenomena, although related, will not always be equivalent, 
potentially leading to differences in the estimation of ischemic 
burden. The method of establishing ischemic burden from the 
dynamic image series in first pass CMR is not identical to that 
used in MPS, which is based on multiple passes producing an 
average of distribution of tracer uptake.
The stress protocols differed slightly between MPS 
and CMR, leading to different hemodynamic parameters. 
Vasodilator stress using adenosine was used for both tech-
niques because dynamic exercise was not possible dur-
ing CMR. However, when adenosine is used for MPS, it is 
desirable to combine it with submaximal dynamic exercise 
to reduce side effects and extracardiac uptake of tracer. The 
accuracy of adenosine MPS with and without additional exer-
cise is similar, and the difference between stress techniques 
would not be expected to have affected the findings.27
Our results can only give an indication of the relative perfor-
mance for conventional 3-slice 2D CMR perfusion imaging. Only 
an adequately powered head-to-head comparison of the 2 acqui-
sition (2D versus 3D) methods can give conclusive evidence of 
their accuracy in determination of ischemic burden. However, as 
demonstrated in this study and observed in phantoms studies,5 3D 
whole-heart acquisition seems to provide a more accurate estima-
tion of ischemic burden than using 3-slice acquisition.
Our analysis method used the clinical standard of visual 
measurement of ischemic burden. Quantitative analysis 
methods have important potential advantages such as higher 
objectivity and the detection of balanced ischemia but have 
not yet been applied to 3D CMR perfusion data sets.
Conclusions
Estimates of ischemic burden from 3D myocardial perfusion 
CMR agreed closely with MPS. The technique was also accu-
rate for the detection of angiographically defined coronary 
obstruction. Combined with CMR assessment of cardiac func-
tion and viability, 3D myocardial perfusion CMR holds promise 
as a complete noninvasive and radiation-free diagnostic and risk 
stratification tool for patients with known or suspected CAD.
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CLINICAL PeRSPeCtIVe
Myocardial perfusion cardiovascular magnetic resonance (CMR) has become an established method for the noninvasive 
diagnosis of coronary artery disease (CAD). Although this technique may be useful for diagnostic purposes, the selective 
spatial coverage may prevent an accurate measurement of ischemic burden. In clinical practice, ischemic burden is most 
commonly measured by myocardial perfusion scintigraphy (MPS). It is an important prognostic factor in CAD and in 
accordance with guidelines can help identify patients who will benefit most from revascularization compared with medical 
therapy. Three-dimensional (3D) myocardial perfusion CMR techniques overcome the problem of limited cardiac coverage 
and are also accurate in the detection of CAD. Measurements of ischemic burden from 3D myocardial perfusion CMR have 
been shown to agree with invasive indices of myocardium at risk and to reduce following percutaneous coronary interven-
tion. However, a direct comparison with MPS has not previously been reported. This study compared ischemic burden 
between MPS and 3D myocardial perfusion CMR in 45 patients. The mean ischemic burden was similar, and there was a 
strong correlation between techniques. In a subset of these patients, the diagnostic accuracy of the 2 methods against inva-
sive coronary angiography was also assessed and noted to be similar. 3D myocardial perfusion CMR may be considered an 
alternative to MPS for detecting the presence and rating the severity of ischemia with the added benefits of higher spatial 
resolution and no exposure to ionizing radiation. In accordance with current guidelines the recently proposed 3D myocardial 
perfusion CMR may help identify patients who will benefit most from revascularization compared with medical therapy. 
Our data suggest that a similar threshold of 10% ischemic burden as used to guide the management of patients with CAD 
with MPS can also be applied to 3D myocardial perfusion CMR. However, larger studies powered to determine the use of 
3D myocardial perfusion CMR as a noninvasive strategy for the diagnosis and risk stratification of patients with suspected 
CAD are required to fully address this question.
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